Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Azoulay

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Blood Reviews|August 4, 2021
Brain-derived neurotrophic factor in hematological malignancies: From detrimental to potentially beneficialDavid Azoulay, Netanel A Horowitz
Journal of Neuroimmunology|March 11, 2008
Low and dysregulated BDNF secretion from immune cells of MS patients is related to reduced neuroprotectionDavid Azoulay, Natali Urshansky, Arnon Karni
The Israel Medical Association Journal : IMAJ|December 15, 2018
BDNF Val66Met is Associated with Pre-existing but not with Paclitaxel-induced Peripheral Neuropathy in an Israeli Cohort of Breast Cancer PatientsAnca Leibovici, Rivka Sharon, David Azoulay
The Journal of Pediatrics|January 16, 2022
Laboratory Indices in Patients with Positive and Borderline Flow Cytometry Eosin-5-Maleimide-Screening Test Results for Hereditary SpherocytosisDavid Azoulay, Ilan Levov, Ety Shaoul, et al.
Journal of Neuroimmunology|August 9, 2005
Lower brain-derived neurotrophic factor in serum of relapsing remitting MS: reversal by glatiramer acetateDavid Azoulay, Veronika Vachapova, Boris Shihman, et al.
Journal of Clinical Neurology (Seoul, Korea)|October 9, 2019
Prediction of Chemotherapy-Induced Peripheral Neuropathy in Patients with Lymphoma and Myeloma: the Roles of Brain-Derived Neurotropic Factor Protein Levels and A Gene PolymorphismDavid Azoulay, Sami Giryes, Roni Nasser, et al.
Journal of Neuroimmunology|May 8, 2009
Interferon-beta therapy up-regulates BDNF secretion from PBMCs of MS patients through a CD40-dependent mechanismDavid Azoulay, Karin Mausner-Fainberg, Nataly Urshansky, et al.
Experimental Hematology|April 30, 2018
Elevated serum BDNF levels are associated with favorable outcome in CLL patients: Possible link to CXCR4 downregulationDavid Azoulay, Yair Herishanu, Mika Shapiro, et al.
Cytometry. Part B, Clinical Cytometry|December 10, 2019
Flow cytometry aneuploidy and cell cycle indexing as a possible tool for differentiating between CD10<sup>+</sup> diffuse large B-cell lymphoma and follicular lymphomaDavid Azoulay, Hector I Cohen, Eugene Dementiev, et al.
International Journal of Molecular Sciences|November 26, 2022
Brain-Derived Neurotrophic Factor (BDNF) Is Associated with Platelet Activity and Bleeding Tendency in Patients with Gaucher DiseaseDavid Azoulay, Mira Naamad, Dafna Frydman, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Blood Reviews|August 4, 2021
Brain-derived neurotrophic factor in hematological malignancies: From detrimental to potentially beneficialDavid Azoulay, Netanel A Horowitz
Journal of Neuroimmunology|March 11, 2008
Low and dysregulated BDNF secretion from immune cells of MS patients is related to reduced neuroprotectionDavid Azoulay, Natali Urshansky, Arnon Karni
The Israel Medical Association Journal : IMAJ|December 15, 2018
BDNF Val66Met is Associated with Pre-existing but not with Paclitaxel-induced Peripheral Neuropathy in an Israeli Cohort of Breast Cancer PatientsAnca Leibovici, Rivka Sharon, David Azoulay
The Journal of Pediatrics|January 16, 2022
Laboratory Indices in Patients with Positive and Borderline Flow Cytometry Eosin-5-Maleimide-Screening Test Results for Hereditary SpherocytosisDavid Azoulay, Ilan Levov, Ety Shaoul, et al.
Journal of Neuroimmunology|August 9, 2005
Lower brain-derived neurotrophic factor in serum of relapsing remitting MS: reversal by glatiramer acetateDavid Azoulay, Veronika Vachapova, Boris Shihman, et al.
Journal of Clinical Neurology (Seoul, Korea)|October 9, 2019
Prediction of Chemotherapy-Induced Peripheral Neuropathy in Patients with Lymphoma and Myeloma: the Roles of Brain-Derived Neurotropic Factor Protein Levels and A Gene PolymorphismDavid Azoulay, Sami Giryes, Roni Nasser, et al.
Journal of Neuroimmunology|May 8, 2009
Interferon-beta therapy up-regulates BDNF secretion from PBMCs of MS patients through a CD40-dependent mechanismDavid Azoulay, Karin Mausner-Fainberg, Nataly Urshansky, et al.
Experimental Hematology|April 30, 2018
Elevated serum BDNF levels are associated with favorable outcome in CLL patients: Possible link to CXCR4 downregulationDavid Azoulay, Yair Herishanu, Mika Shapiro, et al.
Cytometry. Part B, Clinical Cytometry|December 10, 2019
Flow cytometry aneuploidy and cell cycle indexing as a possible tool for differentiating between CD10<sup>+</sup> diffuse large B-cell lymphoma and follicular lymphomaDavid Azoulay, Hector I Cohen, Eugene Dementiev, et al.
International Journal of Molecular Sciences|November 26, 2022
Brain-Derived Neurotrophic Factor (BDNF) Is Associated with Platelet Activity and Bleeding Tendency in Patients with Gaucher DiseaseDavid Azoulay, Mira Naamad, Dafna Frydman, et al.
Pageof 2